JPRN-UMIN000005018招募中2 期
Efficacy and safety of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trial - Efficacy of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trial
Department of Psychiatry, Shimane University School of Medicine0 个研究点目标入组 120 人开始时间: 2011年2月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Personality disorder etc
研究者
相似试验
未知
不适用
The safety and efficacy of Yokukansan in treating neuropsychiatric symptoms of patients with Fronto-Temporal Lobar Degeneration (FTLD)Fronto-Temporal Lobar Degeneration (FTLD)JPRN-UMIN000001897Ehime University Graduate School of Medicine20
未知
不适用
Evaluation of efficacy of yokukansan in patients with dementia with Lewy bodies using NPI-D as an indicator.Dementia with Lewy bodiesJPRN-UMIN000001832Department of Geriatric Medicine, Kyorin University School of Medicine20
已完成
不适用
To investigate the efficacy and safety of Yokukansan for patients with insomniaPsychophysiological insomniaJPRN-UMIN000001412The Jikei university school of medicine10
招募中
不适用
Examination of efficacy of yokukansan for postoperative delirium.postoperative deliriumJPRN-UMIN000004417ippon Medical School Musashi Kosugi Hospital200
已完成
2 期
The efficacy and safety of Yokukansan for BPSD in Alzheimer's disease. a randomized, double-blind, placebo-control trial.s diseaseAlzheimer's diseaseJPRN-UMIN000004325Institute of Development, Aging and Cancer Tohoku university, Department of Geriatrics and Gerontology140